157 related articles for article (PubMed ID: 27765729)
21. The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders.
Park H; Jiang X; Song HJ; Lo Re V; Childs-Kean LM; Lo-Ciganic WH; Cook RL; Nelson DR
Hepatology; 2021 Aug; 74(2):566-581. PubMed ID: 33544904
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study.
Bruno S; Crosignani A; Maisonneuve P; Rossi S; Silini E; Mondelli MU
Hepatology; 2007 Nov; 46(5):1350-6. PubMed ID: 17680653
[TBL] [Abstract][Full Text] [Related]
23. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
Larsen C; Bousquet V; Delarocque-Astagneau E; Pioche C; Roudot-Thoraval F; ; ; Desenclos JC
J Med Virol; 2010 Oct; 82(10):1647-54. PubMed ID: 20827760
[TBL] [Abstract][Full Text] [Related]
25. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
26. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
Limketkai BN; Mehta SH; Sutcliffe CG; Higgins YM; Torbenson MS; Brinkley SC; Moore RD; Thomas DL; Sulkowski MS
JAMA; 2012 Jul; 308(4):370-8. PubMed ID: 22820790
[TBL] [Abstract][Full Text] [Related]
27. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.
Livingston SE; Deubner H; Bruden DL; McMahon BJ; Homan CE; Townshend-Bulson LJ; Bruce MG; Hennessy TW; Williams JL; Gretch DR
Can J Gastroenterol; 2010 Jul; 24(7):445-51. PubMed ID: 20652161
[TBL] [Abstract][Full Text] [Related]
29. Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
Ryom L; Lundgren JD; De Wit S; Kovari H; Reiss P; Law M; El-Sadr W; Monforte AD; Mocroft A; Smith C; Fontas E; Dabis F; Phillips A; Sabin C;
AIDS; 2016 Jul; 30(11):1731-43. PubMed ID: 26752282
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens.
Tayyab GUN; Rasool S; Nasir B; Rubi G; Abou-Samra AB; Butt AA
BMC Gastroenterol; 2020 Apr; 20(1):93. PubMed ID: 32252635
[TBL] [Abstract][Full Text] [Related]
31. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.
Mocroft A; Lundgren J; Gerstoft J; Rasmussen LD; Bhagani S; Aho I; Pradier C; Bogner JR; Mussini C; Uberti Foppa C; Maltez F; Laguno M; Wandeler G; Falconer K; Trofimova T; Borodulina E; Jevtovic D; Bakowska E; Kase K; Kyselyova G; Haubrich R; Rockstroh JK; Peters L;
Clin Infect Dis; 2020 May; 70(10):2131-2140. PubMed ID: 31504296
[TBL] [Abstract][Full Text] [Related]
32. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
33. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication.
Vutien P; Kim NJ; Moon AM; Johnson KM; Berry K; Green PK; Ioannou GN
Aliment Pharmacol Ther; 2024 Feb; 59(3):361-371. PubMed ID: 37955206
[TBL] [Abstract][Full Text] [Related]
35. Childhood cancer among Alaska Natives.
Lanier AP; Holck P; Ehrsam Day G; Key C
Pediatrics; 2003 Nov; 112(5):e396. PubMed ID: 14595083
[TBL] [Abstract][Full Text] [Related]
36. Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study.
Huang TS; Lin CL; Lu MJ; Yeh CT; Liang KH; Sun CC; Shyu YC; Chien RN
J Gastroenterol Hepatol; 2017 Jul; 32(7):1355-1362. PubMed ID: 27930829
[TBL] [Abstract][Full Text] [Related]
37. Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance.
Akuta N; Suzuki F; Sezaki H; Kobayashi M; Fujiyama S; Kawamura Y; Hosaka T; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30381417
[TBL] [Abstract][Full Text] [Related]
38. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
39. HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
Lee MH; Hsiao TI; Subramaniam SR; Le AK; Vu VD; Trinh HN; Zhang J; Jin M; Wong VW; Wong GL; Nguyen MH
Am J Gastroenterol; 2017 Jul; 112(7):1111-1119. PubMed ID: 28440303
[TBL] [Abstract][Full Text] [Related]
40. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
